Representational image of the Oxford-AstraZeneca vaccine, manufactured by the Serum Institute of India under the name Covishield | Photo: ANI
Representational image of the Oxford-AstraZeneca vaccine, manufactured by the Serum Institute of India under the name Covishield | Photo: ANI
Text Size:

New Delhi: Serum Institute of India (SII), the world’s largest vaccine maker, on Wednesday announced a price of Rs 600 per dose for COVID vaccine supplies to private hospitals and Rs 400 per dose to state governments.

In a statement posted on its Twitter handle, SII said it will address the limited capacity by scaling up the vaccine production over the next two months.

“Going ahead, 50 per cent of our capacities will be served to the Government of India’s vaccination programme, and the remaining 50 per cent of the capacity will be for the state governments and private hospitals,” it said.

SII said Covishield vaccine will be available to state governments for Rs 400 per dose and to private hospitals at Rs 600 per dose.


Also read: Between ‘Covid is over’ and universal vaccination cheer, India lost sight of strategy


 

Subscribe to our channels on YouTube & Telegram

Why news media is in crisis & How you can fix it

India needs free, fair, non-hyphenated and questioning journalism even more as it faces multiple crises.

But the news media is in a crisis of its own. There have been brutal layoffs and pay-cuts. The best of journalism is shrinking, yielding to crude prime-time spectacle.

ThePrint has the finest young reporters, columnists and editors working for it. Sustaining journalism of this quality needs smart and thinking people like you to pay for it. Whether you live in India or overseas, you can do it here.

Support Our Journalism

VIEW COMMENTS